<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Pediatr Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">J Pediatr Genet</journal-id>
<journal-id journal-id-type="doi">10.1055/s-00029027</journal-id>
<journal-title-group>
<journal-title>Journal of Pediatric Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">2146-4596</issn>
<issn pub-type="epub">2146-460X</issn>
<publisher>
<publisher-name>Georg Thieme Verlag KG</publisher-name>
<publisher-loc>Stuttgart · New York</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28794905</article-id>
<article-id pub-id-type="pmc">5548525</article-id>
<article-id pub-id-type="doi">10.1055/s-0037-1601335</article-id>
<article-id pub-id-type="publisher-id">1700008</article-id>
<article-categories>
<subj-group>
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Further Clinical Delineation of the MEF2C Haploinsufficiency Syndrome: Report on New Cases and Literature Review of Severe Neurodevelopmental Disorders Presenting with Seizures, Absent Speech, and Involuntary Movements</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Vrečar</surname>
<given-names>Irena</given-names>
</name>
<xref ref-type="aff" rid="AF1700008-1">1</xref>
<xref ref-type="aff" rid="AF1700008-2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Innes</surname>
<given-names>Josie</given-names>
</name>
<xref ref-type="aff" rid="AF1700008-1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jones</surname>
<given-names>Elizabeth A.</given-names>
</name>
<xref ref-type="aff" rid="AF1700008-1">1</xref>
<xref ref-type="aff" rid="AF1700008-3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kingston</surname>
<given-names>Helen</given-names>
</name>
<xref ref-type="aff" rid="AF1700008-1">1</xref>
<xref ref-type="aff" rid="AF1700008-3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reardon</surname>
<given-names>William</given-names>
</name>
<xref ref-type="aff" rid="AF1700008-4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kerr</surname>
<given-names>Bronwyn</given-names>
</name>
<xref ref-type="aff" rid="AF1700008-1">1</xref>
<xref ref-type="aff" rid="AF1700008-3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Clayton-Smith</surname>
<given-names>Jill</given-names>
</name>
<xref ref-type="aff" rid="AF1700008-1">1</xref>
<xref ref-type="aff" rid="AF1700008-3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Douzgou</surname>
<given-names>Sofia</given-names>
</name>
<xref ref-type="aff" rid="AF1700008-1">1</xref>
<xref ref-type="aff" rid="AF1700008-3">3</xref>
<xref ref-type="author-notes" rid="CO1700008-1"></xref>
</contrib>
</contrib-group>
<aff id="AF1700008-1">
<label>1</label>
<institution>Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Academic Health Sciences Centre, Manchester, United Kingdom</institution>
</aff>
<aff id="AF1700008-2">
<label>2</label>
<institution>Clinical Institute of Medical Genetics, University Medical Centre of Ljubljana, Ljubljana, Slovenia</institution>
</aff>
<aff id="AF1700008-3">
<label>3</label>
<institution>Division of Evolution and Genomic Sciences, University of Manchester, School of Biological Sciences, Manchester, United Kingdom</institution>
</aff>
<aff id="AF1700008-4">
<label>4</label>
<institution>Department of Clinical Genetics, Our Lady's Children Hospital Crumlin, Dublin, Ireland</institution>
</aff>
<author-notes>
<corresp id="CO1700008-1"><bold>Address for correspondence </bold>Sofia Douzgou, MD, PhD <institution>Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Saint Mary's Hospital</institution><addr-line>Oxford Road, Manchester M13 9WL</addr-line><country>United Kingdom</country><email>sofia.douzgou@cmft.nhs.uk</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>12</day>
<month>4</month>
<year>2017</year>
</pub-date>
<volume>6</volume>
<issue>3</issue>
<fpage>129</fpage>
<lpage>141</lpage>
<history>
<date date-type="received">
<day>27</day>
<month>1</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>2</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© Thieme Medical Publishers</copyright-statement>
</permissions>
<abstract>
<p>
Mutations in the
<italic>MEF2C</italic>
(
<italic>myocyte enhancer factor 2</italic>
) gene have been established as a cause for an intellectual disability syndrome presenting with seizures, absence of speech, stereotypic movements, hypotonia, and limited ambulation. Phenotypic overlap with Rett's and Angelman's syndromes has been noted. Following the first reports of 5q14.3q15 microdeletions encompassing the
<italic>MEF2C</italic>
gene, further cases with point mutations and partial gene deletions of the
<italic>MEF2C</italic>
gene have been described. We present the clinical phenotype of our cohort of six patients with MEF2C mutations and compare our findings with previously reported patients as well as with a growing number of genetic conditions presenting with a severe neurodevelopmental, Rett-like, phenotype. We aim to add to the current knowledge of the natural history of the “MEF2C haploinsufficiency syndrome” as well as of the differential diagnosis, clinical management, and genetic counseling in this diagnostically challenging group of patients.
</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>MEF2C</kwd>
<kwd>intellectual disability</kwd>
<kwd>speech delay</kwd>
<kwd>epilepsy</kwd>
<kwd>involuntary movements</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>